Steroid-Refractory Chronic Graft-versus-Host Disease Treated with Ruxolitinib: A Narrative Review of Symptom Burden and Return to Daily Life. Journal of Clinical Case Studies and Reviews, [S. l.], v. 4, n. 1, p. 31–36, 2023. DOI: 10.5281/zenodo.22227762. Disponível em: https://pragmajournals.org/index.php/JCCSR/article/view/311. Acesso em: 30 oct. 2026.